ESR1 and breast carcinoma: As described previously (Fanning et al., 2016), Förster resonance energy transfer (FRET) assays were used to evaluate the interaction of wild-type and Y537S and D538G mutant ERα with steroid receptor coactivator 3 (SRC3), a key coregulator in breast cancer cells.